F068 Journal Watching
DESCRIPTION
The Journal Watching forum reviews the literature of the past year to digest and summarize the highest impact articles to save you time and keep you up to date. Experts from across the country come together for a session that is high yield, showcasing advances in Melanoma research, Dermatopathology, Surgical Dermatology, Medical and Pediatric Dermatology. Bring your questions, there will be time at the end for discussion.
LEARNING OBJECTIVES
Recognize advances in the diagnosis and/or management of melanoma.
Describe the latest discoveries in MOHS & dermatologic surgery.
Identify current innovations in medical and pediatric dermatology.
SCHEDULE
3:30 PM
Welcome and introduction
Mary Wu Chang, MD, FAAD
3:32 PM
Medical Dermatology Highlights
Jeffrey Phillip Callen, MD, FAAD
3:49 PM
What's new in Dermatopathology?
Kenneth Y. Tsai, MD, PhD, FAAD
4:06 PM
Recent Advances in Pediatric Dermatology
Mary Wu Chang, MD, FAAD
4:23 PM
Melanoma: What you need to know
Hensin Tsao, MD, PhD, FAAD
4:41 PM
Innovations in Lasers and Cosmetic Dermatology
Sandy Sharon Tsao, MD, FAAD
4:58 PM
Mohs and Dermatologic Surgery Pearls
Murad Alam, MD, MSCI, MBA, FAAD
5:15 PM
Q&A
DIRECTOR
Mary Wu Chang, MD, FAAD
SPEAKERS
Murad Alam, MD, MSCI, MBA, FAAD
Jeffrey Phillip Callen, MD, FAAD
Kenneth Y. Tsai, MD, PhD, FAAD
Hensin Tsao, MD, PhD, FAAD
Sandy Sharon Tsao, MD, FAAD
DISCLOSURES
Murad Alam, MD, MSCI, MBA, FAAD
No financial relationships exist with ineligible companies.
Jeffrey Phillip Callen, MD, FAAD
3M Pharmaceuticals – Stockholder Public Company(No Compensation Received); Abbott Laboratories – Stockholder Public Company(No Compensation Received); AbbVie – Stockholder Public Company(No Compensation Received); Allergan, Inc – Stockholder Public Company(No Compensation Received); Amgen – Stockholder Public Company(No Compensation Received); Biogen – Data Safety Monitoring Board(Honoraria); Celgene – Stockholder Public Company(No Compensation Received); Elsevier Inc. – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Johnson and Johnson – Stockholder Public Company(No Compensation Received); Merck & Co., Inc – Stockholder Public Company(No Compensation Received); Pfizer Inc. – Stockholder Public Company(No Compensation Received); Procter & Gamble Company – Stockholder Public Company(No Compensation Received); Proivant – Data Safety Monitoring Board(Fees); UpToDate, Inc. – Other(Honoraria);
Mary Wu Chang, MD, FAAD
No financial relationships exist with ineligible companies.
Kenneth Y. Tsai, MD, PhD, FAAD
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); Ankyra Therapeutics – Independent Contractor(Grants/Research Funding); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria); Worldcare Clinical, LLC – Consultant (1099 relationship)(Fees);
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);